News / Korea / yonhap_finance
Curacle Announces 100 Billion Won Rights Offering for Operational Funding
Health Technology · Biotechnology · yonhap_finance · 2026-09-04
115180
Curacle has decided to raise approximately 100 billion KRW through a rights offering to secure working capital, issuing 7.1 million new shares.
What Happened
Offering Details: KOSDAQ-listed Curacle has announced a capital increase through a rights offering followed by a public subscription for any unsubscribed shares. The company aims to raise approximately 100 billion KRW to support its operations.
Share Issuance: The company will issue 7.1 million new common shares at a fixed price of 14,310 KRW per share. This move is intended to bolster the company's liquidity position.
Strategic Purpose: The proceeds from this issuance are earmarked for operational expenses. By securing these funds, Curacle intends to maintain its business momentum and ensure sufficient working capital for its ongoing projects.
Investor Impact: The announcement of a large-scale capital raise often leads to concerns regarding share dilution for existing shareholders. Market participants will be monitoring the subscription results and the company's subsequent financial performance.